-- Sichuan Hebang Biotechnology's (SHA:603077) net profit attributable to shareholders in the first quarter skyrocketed 1,287% to 173.6 million yuan from 12.5 million yuan a year earlier, according to a Shanghai bourse filing on Tuesday.
Earnings per share surged 1,308% year on year to 0.0169 yuan from 0.0012 yuan.
Operating revenue dropped 20% to 1.39 billion yuan from 1.73 billion yuan in the prior year.
The Chinese biotechnology company's shares fell 7% during the afternoon trade.